Activity Overview
Please read the following information about this continuing pharmacy education (CPE) activity before accessing the presentation using the link located at the bottom of this page.
Release Date: October 15, 2009 Expiration Date: March 1, 2011
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (ACPE Activity # 204-000-09-423-H01P).
Methods and Format
This is an online activity consisting of audio and slides, a post-test, and an activity evaluation tool. Participants should claim continuing education credit for this internet-based educational activity only if they have not claimed credit for the live webinar. Participants must view the entire presentation, take the activity post-test, and complete the course evaluation to receive continuing pharmacy education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing pharmacy education credit immediately. The estimated time to complete this activity is 1 hour. This activity is provided free of charge.
Target Audience
This continuing pharmacy education activity was planned to meet the needs of pharmacists practicing or with an interest in anticoagulation.
Activity Content
Click here to view an overview of the activity content.Learning Objectives
After participating in this knowledge-based CPE activity, participants should be able to
- Explain the findings and implications of data from a clinical trial of the efficacy and safety of antithrombotic therapy presented at the International Society on Thrombosis and Haemostasis (ISTH) meeting.
- Identify strengths and limitations of study methodology and other issues related to validity that should be taken into consideration in applying the clinical research findings pertaining to antithrombotic therapy presented at the ISTH meeting in the patient care setting.
- Discuss an unresolved controversy and a need for future clinical research involving antithrombotic agents.
Faculty
Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology)
Associate Professor of Pharmacy Practice
College of Pharmacy
University of Nebraska Medical Center
Omaha, Nebraska
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of activity content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology), declares that he has served on the speakers bureau for sanofi-aventis and as a consultant for Eli Lilly and Co., sanofi-aventis, and The Medicines Company.
Kristi N. Hofer, Pharm.D., declares that she has no relationships pertinent to this activity.
This activity is supported by an educational grant from sanofi-aventis U.S.
Launch Presentation*
Highlights from the XXII Congress of the International Society on Thrombosis and Haemostasis: Noteworthy News for Pharmacists Managing Antithrombotic Therapy (55 minutes)*Allow additional time to complete the post-test and evaluation.
Download Post-Test
Click here to print the post-test for your reference. Please note that to be eligible for continuing pharmacy education credit, you must go to the ASHP Learning Center and complete the test online.
